Expert Review of Clinical Pharmacology

译名:临床药理学专家评论

SCIEJCR Q2中科院3区

3-5

2026

影响因子区间

平台估算

投稿周期

8%

2025

中国作者发文占比

3150 CHF

费用说明

收费

期刊简介:Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.Clinical Pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.

【译文】药物开发技术的进步正在产生创新的新疗法,从可能救命的新药到生活方式产品。然而,近年来,开发新药的成本急剧上升,对药物耐药性和药物经济学的担忧也日益凸显。临床试验中出现的副作用不断提醒我们严格的安全性和毒性测试的重要性。此外,药物基因组学和针对治疗的‘个性化’方法的出现将要求对药物评估和医疗服务提供新的方法。临床药理学在现代生物医学实践中应对这些挑战发挥着至关重要的作用。

出版社
Taylor & Francis
语言
English
学科
医学
ISSN
1751-2433
eISSN
1751-2441
出版频率
月刊
创刊年份
2010
投稿网址
https://mc.manuscriptcentral.com/erf
最近更新
2026-04-02 18:16:40
Expert Review of Clinical Pharmacology

指标当前值近三年趋势
JCR分区Q2
暂无
中科院分区3区
暂无
影响因子区间3-5
暂无